Data / Form D filings / PERFUSIX USA, Inc.
PERFUSIX USA, Inc.: Form D filing
PERFUSIX USA, Inc., a biotechnology company in Greenwood Village, CO, filed a Form D with the SEC in 2013. The latest, on May 22, 2013, reports $800,000 sold of a $800,000 offering to 1 investor.
Find out what PERFUSIX USA, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8547 E ARAPAHOE RD, SUITE J-448, Greenwood Village, CO, 80112
- Phone
- (303) 523-2567
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2011
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1577439
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 22, 2013 | New notice | $800,000 | $800,000 | $0 | 1 | May 10, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chris Jaynes | Executive Officer, Director | |
| Marcelo Cypel | Director | |
| Tom Waddell | Director | |
| James Edgemond | Director | |
| Tim Klug | Executive Officer, Director | |
| Shaf Keshavjee | Executive Officer, Director |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of May 20, 2013 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PERFUSIX USA, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.